Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
skin irritation: not irritating (OECD 439; GLP)
eye irritation: not irritating (OECD 492; GLP)
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2021-01-12 to 2021-01-15
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 439 (In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method)
- Version / remarks:
- 2015-07-28
- Deviations:
- yes
- Remarks:
- OECD 439 (2020): Pre-test for colour interference was carried out using the MatTek Protocol, i.e. only performed with test chemical in water and no spectral analysis in the range of 570 nm. No historical data of pos. and neg. control are available.
- GLP compliance:
- yes
- Test system:
- human skin model
- Source species:
- human
- Cell type:
- other: normal, human epidermal keratinocytes
- Cell source:
- other: humans
- Source strain:
- other: not applicable
- Details on animal used as source of test system:
- not applicable
- Justification for test system used:
- This test uses the EpiDerm™ reconstructed human epidermis model (MatTek) which consists of normal human-derived epidermal keratinocytes (NHEK) and therefore represents in vitro the target organ of the species of interest and closely resembles the biochemical and physiological properties of the upper parts of the human skin, i.e. the epidermis.
- Vehicle:
- unchanged (no vehicle)
- Details on test system:
- RECONSTRUCTED HUMAN EPIDERMIS (RHE) TISSUE
- Model used: EpiDermTM (EPI-200-SITor EPI-212-SIT; MatTek)
- Tissue lot number: 33786
TEST FOR MTT INTERFERENCE
Approximately 25 mg test substance was added to 1.0 mL of MTT medium in a clear glass vial. After 60 minutes of incubation at 37.2 - 37.4 °C, in an atmosphere containing 5 % CO2, the mixture was shaken and evaluated for presence and intensity of staining/coloration. A vial of MTT medium served as a control. No change was noted.
TEST FOR COLOUR INTERFERENCE
25 mg of test substance was added to 0.3 mL of deionized water, in a clear glass vial. After 60 minutes of incubation at 37.2 - 37.4 °C, in an atmosphere containing 5 % CO2, the mixture was shaken and evaluated for presence and intensity of staining/coloration. No change was noted.
CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE AND COLOUR INTERFERENCE
Since the test item/ water solution did not change colour and the test item did not interfere with MTT in the pre-experiments, no additional tissues were necessary in the main experiment.
TEMPERATURE USED FOR TEST SYSTEM
- Temperature used during treatment / exposure: 37.1 - 37.2 °C and ambient temperatur
- Temperature of post-treatment incubation: 37.2 - 37.3 °C
REMOVAL OF TEST MATERIAL AND CONTROLS
- The tissues were rinsed with sterile DPBS by filling and emptying the tissue insert at least 15 times to remove any residual test material. A constant stream of DPBS was to dislodge the test substance. Cotton swabs were also used to aid in removal of the residual test material.
- After the last rinse, the insert was completely submerged 3 times in a container filled with 150 mL DPBS while gently swishing. The tissue insert was rinsed inside and out with sterile DPBS one final time and the insert was gently shaken and blotted to remove excess liquid.
EXPOSURE
- After the pre-incubation at 37.1 - 37.3 °C and 5 % CO2 for 60 minutes, the inserts were transferred from the upper wells to fresh media in the lower wells of the 6-well plate and further incubated overnight for ~ 18 hours at 37.0 - 37.1 °C and 5 % CO2.
- The upper row of three, 6-well plates were filled with 0.9 mL of assay medium per well. Two plates were prepared for each test substance and one plate for the control substance. Pre-incubated plates were removed from the incubator a few minutes before exposure to the chemicals.
- The tissues were wetted with 25 µL DPBS prior to application.
- Approximately 25 mg of the test substance, and 30 μL of negative control or positive control were added to the surface of three single viable tissues. The tissues were placed in the incubator (37 °C, 5 % CO2) for 35 ± 1 minutes. Then all tissues were removed from the incubator and placed in the sterile hood at ambient temperature until a total of 60 ± 1 minutes.
- The tissue inserts were transferred to previously prepared 6-well plates containing 0.9 mL of assay medium in 3 wells (top row). The tissues were swabbed to remove moisture from the surface. The tissues were incubated for 26 hours at 37.2 - 37.3 °C and 5 % CO2. The plates were removed, and the remaining 3 lower wells were filled with 0.9 mL of fresh assay medium. The inserts were transferred to the freshly filled wells and the plates were placed back into the incubator for an additional ~20 hours at 37.2 - 37.3 °C and 5 % CO2.
MTT DYE USED TO MEASURE TISSUE VIABILITY AFTER TREATMENT
- MTT concentration: 1 mg/mL
- Incubation time: ~3 hours (37.2 - 37.3 °C, 5 % CO2)
- Inserts were removed from the 6-well plates, and residual media was blotted as needed and transferred into appropriately labelled wells of a 24-well plate containing 300 μL of prepared MTT medium or a blank well. The plates were incubated.
- After the 3 hour, the MTT medium was aspirated from all the wells and discarded appropriately. The wells were rinsed with DPBS three times. After the final rinse was aspirated, the inserts were transferred to a fresh 24-well plate. One mL of isopropanol (extraction solution MTT-100-EXT) was added to each insert and the plate was sealed with Parafilm®. Extraction was performed for 2 hours at room temperature on a shaker (120 rpm). The tissues were discarded and an additional 1 mL of isopropanol was added to the well. The extract in each well was mixed and then duplicate 200 μL aliquots of each were transferred into a 96-well flat bottom microtiter plate using the plate design below for OD measurement. Isopropanol was used as blanks.
NUMBER OF REPLICATE TISSUES:
- Three tissue replicates for test item and controls
PREDICTION MODEL / DECISION CRITERIA
Optical density (OD) was measured in a 96-well plate spectrophotometer using a wavelength of 570 nm, without a reference filter.
Using the resulting OD, viability of the tissue for each treatment group was determined:
Relative viability TS (%) = [ODTS / Mean of ODNC] x 100
Relative viability NC (%) = [ODNC / Mean of ODNC] x 100
Relative viability PC (%) = [ODPC / Mean of ODNC] x 100
For each test substance, negative control, and positive control, the mean relative viability of the tissues was calculated and used for classification. If the mean tissue viability is ≤ 50%, the test substance is predicted to be an irritant (GHS Category 2). If the mean tissue viability is >50%, a non-irritant is confirmed. - Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- TEST MATERIAL
- Amount(s) applied: Three tissue replicates were wetted with 25 µL of DPBS prior to application and then 25 mg of the neat test substance was added to the viable tissue surface.
VEHICLE
- Amount(s) applied: not applicable
NEGATIVE CONTROL
- Amount(s) applied (volume or weight): 30 µL DPBS
POSITIVE CONTROL
- Amount(s) applied (volume or weight): 30 µL of 5 % SDS solution - Duration of treatment / exposure:
- 60 minutes
- Duration of post-treatment incubation (if applicable):
- ~46 hours
- Number of replicates:
- Number of EpiDerm tissues per group: triplicates
- Irritation / corrosion parameter:
- % tissue viability
- Value:
- 104.8
- Vehicle controls validity:
- not examined
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- TEST FOR MTT INTERFERENCE
In the pre-experiment for MTT interference the test item did not reduce MTT to Formazan salt.
TEST FOR COLOUR INTERFERENCE
In the pre-experiment for colour interference the test item did not change colour when mixed with deionised water.
DEMONSTRATION OF TECHNICAL PROFICIENCY:
Prior to routine use of EpiDermTM for regulatory purposes, the laboratory demonstrated technical proficiency by correctly predicting the ten proficiency chemicals listed in Table 1 of OECD TG 439. The respective Laboratory Technical Proficiency Data are attached in the field "Overall remarks, attachments" below.
ACCEPTANCE OF RESULTS:
- the mean OD570 of the tissue replicates treated with the negative control is ≥ 0.8 and ≤ 2.8 (1.994) in accordance with OECD TG 439.
- the viability of the tissue replicates treated with the positive control is ≤ 20% (2.6).
- the standard deviation from individual % tissue viablitiies calculated from 3 identically treated replicates is ≤ 18 (0.13 - 5.29). - Interpretation of results:
- GHS criteria not met
- Conclusions:
- In conclusion, in this study and under the experimental conditions reported, Titanium, iron and aluminium pseudobrookite and rutile is non-irritant to skin and does not require classification and labelling for skin irritation or corrosivity according to UN GHS and EU CLP.
Reference
Optical density and viability results I
Treatment Group |
Tissue No. |
Raw data OD 570 nm |
Blank Corrected data OD 570 nm |
Mean OD of aliquots |
% of viability |
||
Aliq. 1 |
Aliq. 2 |
Aliq. 1 |
Aliq. 2 |
||||
Blank |
|
- |
- |
- |
- |
0.0872 |
- |
Negative Control |
1 |
2.0752 |
2.1466 |
1.988 |
2.059 |
2.024 |
101.5 |
2 |
1.9928 |
2.0178 |
1.906 |
1.931 |
1.918 |
96.2 |
|
3 |
2.1368 |
2.1205 |
2.050 |
2.033 |
2.041 |
102.4 |
|
Positive Control |
1 |
0.1404 |
0.1417 |
0.053 |
0.055 |
0.054 |
2.7 |
2 |
0.1356 |
0.136 |
0.048 |
0.049 |
0.049 |
2.4 |
|
3 |
0.1376 |
0.1381 |
0.050 |
0.051 |
0.051 |
2.5 |
|
Test Item |
1 |
2.182 |
2.1544 |
2.095 |
2.067 |
2.081 |
104.3 |
2 |
2.0709 |
2.0822 |
19.984 |
1.995 |
1.989 |
99.7 |
|
3 |
2.276 |
2.2976 |
2.189 |
2.210 |
2.200 |
110.3 |
Optical density and viability results II
Tissue-Type |
Substance |
Average OD |
SD (OD) |
Average % viability |
SD (viability) |
CV (%) |
viable |
Negative Control (DPBS) |
1.994 |
0.067 |
100.0 |
3.34 |
3.34 |
Positive Control (5% SDS) |
0.051 |
0.003 |
2.6 |
0.13 |
5.18 |
|
Test Item |
2.090 |
0.105 |
104.8 |
5.29 |
5.04 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2021-01-13 to 2021-01-14
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- 2019-06-18
- Deviations:
- yes
- Remarks:
- In the pre-test for Colour Interference the absorption of the test item water solution in the range of 570 nm was not evaluated by OD measurement. No historical data of pos. and neg. control are available.
- GLP compliance:
- yes
- Details on test animals or tissues and environmental conditions:
- JUSTIFICATION OF THE TEST METHODS AND CONSIDERATIONS REGARDING APPLICABILITY:
This in vitro method is recommended to identify chemicals that do not require classification for eye irritation or serious eye damage according to UN GHS (UN GHS “No Category”) without further testing within a tiered testing strategy from those requiring classification and labelling (UN GHS categories 1 and 2). Therefore, it can be used for regulatory purposes as an initial step in the bottom-up approach or as one of the last steps in a top-down approach to test eye irritation/corrosion potential. It is not intended to differentiate between UN GHS “Category 1” (serious eye damage) and UN GHS “Category 2” (eye irritation) which would require additional testing. Ocular irritation potential is predicted by the relative viability of the tissue after a single exposure to the test substance. Relative viability is determined by measuring the MTT dye to formazan conversion by the EpiOcular™ tissue construct after topical exposure to the test substance.
RhCE TISSUE CONSTRUCT USED: EpiOcular™ (Lot No.:31770; OCL-200-EIT and MTT-100 assy kit; source: MatTek Corporation (82105 Bratislava, Slovakia))
The test was carried out with the EpiOcular™ reconstructed human cornea-line epithelium (RhCE) model (MatTek). The model consists of normal, human-derived epidermal keratinocytes which have been cultured to form a stratified, highly differentiated squamous epithelium morphologically similar to that found in a human cornea. The EpiOcular™ RhCE tissue construct consists of at least 3 viable layers of cells and a non-keratinized surface, showing a cornea-like structure analogous to that found in vivo. - Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 50 mg of the neat test substance was applied to the tissue surface. All tissues were pre-wetted with 20 µL DPBS prior application and incubated for 30 min at 37.2 °C. - Duration of treatment / exposure:
- 6 hours
- Observation period (in vivo):
- not applicable
- Duration of post- treatment incubation (in vitro):
- about 18 hours
- Number of animals or in vitro replicates:
- Number of EpiOcular tissues per group: duplicates
- Details on study design:
- PRE-TEST FOR MTT INTERFERENCE
Approximately 50 mg of test substance or 50 μL deionized water (control) was added to 1 mL aliquot of MTT medium. After ~3 hours of incubation (37.2 - 37.4 °C, 5% CO2), the mixtures were evaluated for change in coloration to purple/blue.
PRE-TEST FOR COLOUR INTERFERENCE
Approximately 50 mg of the test substance was added to both 1 mL of deionized water and 2 mL of isopropanol. After 60 minutes of incubation (37.2 - 37.4 °C, 5% CO2) in deionized water, or 3 hours at ambient temperature in isopropanol. The water solution was evaluated for the presence and intensity of staining/coloration. For the isopropanol solution the absorption in the range of 570±20 nm was evaluated by OD measurement.
CONTROL TISSUES USED IN CASE OF MTT DIRECT INTERFERENCE AND COLOUR INTERFERENCE
Since the test item/ water and test item/ isopropanol solutions did not change colour and the test item did not interfere with MTT, no additional tissues were necessary in the main experiment.
DETAILS OF THE TEST PROCEDURE USED
- Pre-warming:
EpiOcularTM tissues were equilibrated at room temperature for 15 min. The inserts with the tissues were transferred into 6-well-plates containing 1.0 ml assay medium and incubated for 60 minutes (37.2 °C, 5 % CO2). Afterwards, the medium was changed and a further pre-incubation for approximately 16 hours (37.0 - 37.3 °C, 5 % CO2) follows.
-Pre-treatment:
After pre-warming and prior to application of the test item respectively the controls, all tissues were pre-wetted with 20 µL DPBS and incubated for 30 min (37.2 °C, 5 % CO2).
- Treatment/Exposure:
Concurrent negative and positive control were applied at a volume of 50 µL and for the test substance 50 mg to the tissue surface and incubated for 6 h in assay medium (37.1 - 37.3 °C, 5 % CO2)
- Rinsing:
Afterwards all tissues were rinsed 3 times in 100 - 150 mL DPBS.
- Post-exposure immersion:
The inserts were transferred to new 12-well plates containing 5 ml assay medium and incubated for 35 min at room temperature and allowed to soak.
Post-exposer incubation:
The tissues were transferred into a 6-well plate with 1 ml assay medium and were incubated for a for about 18 h (37.3 °C, 5 % CO2).
- MTT Assay:
The tissues were placed into the 24-well plate containing 300 µL of MTT (1 mg/ mL) solution and were incubated for 3 hours (37.2 °C, 5 % CO2).
The inserts were transferred to 6-well plates containing 1 mL of isopropanol in each well. Samples were shaken for 2 hours at room temperature on a plate shaker. A volume of 1 mL of isopropanol was added to the extraction solution and the solution was mixed in each well. Duplicate 200 μL aliquots of each were transferred into a 96-well plate. Isopropanol was used as blanks.
-Measurement:
Optical density (OD) was read in a 96-well plate spectrophotometer using a wavelength of 570 nm without using a reference filter.
TEST ACCEPTANCE CRITERIA
The test meets acceptance criteria:
- mean absolute OD570 nm of the negative control is > 0.8 and < 2.5
- mean relative tissue viability of the positive control is < 50%
- relative tissue viability difference of replicate tissues is < 20%
DESCRIPTION OF DATA EVALUATION
Optical density (OD) was read in a 96-well plate spectrophotometer using a wavelength of 570 nm without using a reference filter.
Blank corrected OD values were calculated by subtracting the OD of the blank wells from the OD of all other measured wells. The mean OD value of each pair of aliquots was then calculated for each tissue.
The mean corrected OD for treated viable tissues was calculated. The resulting mean OD for the negative control treated tissue corresponds to 100% viability for the assay.
Viability [%] = corrected test article OD / corrected mean negative control OD x 100
PREDICTION MODEL
If the test item-treated tissue viability is > 60% after exposure and post-exposure incubation relative to the negative control treated tissue viability, the test item is identified as not requiring classification and labelling according to UN GHS (No Category).
If the test item-treated tissue viability is ≤ 60% after exposure and post-exposure incubation relative to negative control treated tissue viability, the test is identified as irritant to eyes and requires classification and labelling according to UN GHS (Category 2). - Irritation parameter:
- mean percent tissue viability
- Value:
- 65.7
- Vehicle controls validity:
- not examined
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- TEST FOR MTT INTERFERENCE
In the pre-experiment for MTT interference no significant colour change was noted, so the test item did not reduce MTT to Formazan salt.
TEST FOR COLOUR INTERFERENCE
In the pre-experiment for colour interference the test item did not change colour when mixed with deionised water or isopropanol. The connected OD of the test item isopropanol solution was well below 0.08.
ACCEPTANCE OF RESULTS:
- mean absolute OD570 nm of the negative control is > 0.8 and < 2.8 (1.850)
- mean relative tissue viability of the positive control is < 50% (47.5%)
- relative tissue viability difference of replicate tissues is < 20% (9.21 - 19.64) - Interpretation of results:
- GHS criteria not met
- Conclusions:
- In conclusion, in this study and under the experimental conditions reported, Titanium, iron and aluminium pseudobrookite and rutile is non-irritant to eyes and does not require classification and labelling for eye irritation or serious eye damage according to UN GHS and EU CLP.
Reference
Optical density and viability results I
Treatment Group |
Tissue No. |
Raw data OD 570 nm |
Blank Corrected data OD 570 nm |
Mean OD of aliquots |
% of viability |
||
Aliq. 1 |
Aliq. 2 |
Aliq. 1 |
Aliq. 2 |
||||
Blank |
|
- |
- |
- |
- |
0.0866 |
- |
Negative Control |
1 |
1.8371 |
1.8662 |
1.751 |
1.780 |
1.765 |
95.4 |
2 |
2.0065 |
2.0375 |
1.920 |
1.951 |
1.935 |
104.6 |
|
Positive Control |
1 |
0.8543 |
0.8567 |
0.768 |
0.770 |
0.769 |
41.6 |
2 |
1.0846 |
1.0658 |
0.998 |
0.979 |
0.989 |
53.4 |
|
Test Item |
1 |
1.1152 |
1.1261 |
1.029 |
1.040 |
1.034 |
55.9 |
2 |
1.4841 |
1.4839 |
1.398 |
1.397 |
1.397 |
75.5 |
Optical density and viability results II
Substance |
Average Optical Density reading |
SD (Optical Density) |
Average % Viability |
SD (Viability) |
Test Item |
1.216 |
0.363 |
65.7 |
19.64 |
Negative Control (deionized water) |
1.850 |
0.170 |
100.0 |
9.21 |
Positive Control (methyl acetate) |
0.879 |
0.220 |
47.5 |
11.87 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Skin irritation
The substance was not observed to be a skin irritant in a reliable in vitro skin irritation study according to OECD 439.
Eye irritation
The substance was not observed to be an eye irritant in a reliable in vitro eye irritation study according to OECD 492.
Justification for classification or non-classification
Skin irritation:
The substance does not possess a skin irritation potential based on an in vitro OECD 439 test and does not require classification as skin irritant according to Regulation (EC) No 1272/2008 and its subsequent adaptations.
Eye irritation:
The substance does not possess an eye irritation potential based on an in vitro OECD 492 test and does not require classification as eye irritant according to Regulation (EC) No 1272/2008 and its subsequent adaptations.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.